Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyTue, 23 Jul 2024 02:17:34 +0200Thu, 11 Apr 2024 14:48:00 +0200Human medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 13, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/febuxostat-viatris-previously-febuxostat-mylanHuman medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 13, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/febuxostat-viatris-previously-febuxostat-mylanThu, 11 Apr 2024 14:48:00 +0200Human medicineFebuxostat Viatris (previously Febuxostat Mylan) : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-4374-en.pdfFebuxostat Viatris (previously Febuxostat Mylan) : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-4374-en.pdfTue, 16 Jan 2024 12:38:00 +0100Human medicine